KR20150117091A - Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta - Google Patents

Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta Download PDF

Info

Publication number
KR20150117091A
KR20150117091A KR1020140042396A KR20140042396A KR20150117091A KR 20150117091 A KR20150117091 A KR 20150117091A KR 1020140042396 A KR1020140042396 A KR 1020140042396A KR 20140042396 A KR20140042396 A KR 20140042396A KR 20150117091 A KR20150117091 A KR 20150117091A
Authority
KR
South Korea
Prior art keywords
extract
cosmetic composition
fermented
weight
skin
Prior art date
Application number
KR1020140042396A
Other languages
Korean (ko)
Other versions
KR101658799B1 (en
Inventor
양승화
민정환
문영섭
문창훈
안용석
고창익
이태호
Original Assignee
(주)컬러핑크알앤디
(주)청룡수산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)컬러핑크알앤디, (주)청룡수산 filed Critical (주)컬러핑크알앤디
Priority to KR1020140042396A priority Critical patent/KR101658799B1/en
Publication of KR20150117091A publication Critical patent/KR20150117091A/en
Application granted granted Critical
Publication of KR101658799B1 publication Critical patent/KR101658799B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9761Cupressaceae [Cypress family], e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition for skin whitening, which is safe to skin and effective in whitening skin by using a fermented extract of Horse placenta and medical herb ingredients with reduced unique smell of Horse placenta and toxicity. The composition comprises 0.01-15 wt% active ingredients of a fermented extract of Horse placenta, a Dendropanax trifidus extract, a citron extract, a quince extract, a Juniperus chinensis extract, and a Lonicera maackii extract, with respect to the total weight of the cosmetic composition.

Description

마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물 {Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta}[0001] The present invention relates to a skin whitening cosmetic composition comprising a fermented product of Matthias mellifera and a herbal medicine ingredient and a cosmetic composition having a skin-lightening effect containing a natural component and a fermented extract of horse placenta,

본 발명은 피부미백 화장료 조성물에 관한 것이며, 보다 구체적으로는 마태반 발효물 및 생약성분을 이용하여 피부에 안전하고 제형의 안정성이 우수한 피부미백 화장료 조성물에 관한 것이다.The present invention relates to a skin whitening cosmetic composition, and more particularly, to a skin whitening cosmetic composition which is safe to the skin and has excellent formulation stability by using a fermented product of mackerel and a herbal composition.

일반적으로 피부의 노화현상, 기미, 주름, 또는 주근깨 등이 많아지는 현상은 콜라겐(collagen)의 부족 내지 멜라닌(melanin) 생성의 증가에 따라 나타나는 현상으로서, 피부의 노화는 크게 내적 노화와 외적 노화로 구분되며, 주로 외적 요인에 의하여 노화가 촉진되며, 피부의 외적 노화는 주로 자외선 등의 환경적 요인이 크기 때문에 자외선이 우리들의 삶에 필수적이기는 하지만 장기간 노출되면 시간이 지남에 따라 피부의 조기 노화가 촉진되는 원인이 된다.In general, aging of the skin, wrinkles, wrinkles, or freckles are caused by the increase in the production of collagen (melanin) due to lack of collagen. Skin aging is mainly caused by internal aging and external aging And aging is promoted mainly by external factors. Although aging of the skin is mainly caused by environmental factors such as ultraviolet rays, ultraviolet rays are essential for our life. However, when exposed for a long period of time, It causes accelerated.

자외선에 의한 피부 흑화 현상은 1차 흑화(immediate pigment darkening)와 2차 흑화(delated tannig)로 나눌 수 있는데, 1차 흑화는 멜라닌의 생합성과는 관계없이 기존의 멜라닌의 화학적인 산화 반응을 통하여 보다 진한색으로 변화하는 현상으로서 멜라닌의 증가를 수반하지 않는 현상이며, 2차 흑화는 티로시나아제의 활성화에 의해 멜라닌이 새롭게 생성되어 발생하는 현상이다. 멜라닌세포는 단파장의 자외선을 흡수하여 피부에 저해가 되는 자외선이 진피 내로 침입하는 것을 막아주는 역할을 담당하는 인체에 있어서 반드시 필요한 세포이며, 멜라닌은 멜라닌세포의 멜라노좀에서 생성되는 것으로 피부의 각질층에 분포되며, 멜라닌 색소의 많고 적음에 의하여 외부로 보이는 피부색이 결정된다.The skin blackening phenomenon caused by ultraviolet rays can be divided into immediate pigment darkening and delated tannig. The primary blackening is caused by the chemical oxidation reaction of melanin, regardless of the biosynthesis of melanin, It is a phenomenon that changes to dark color and does not involve an increase of melanin. Secondary blackening is a phenomenon that melanin is newly generated by activation of tyrosinase. Melanocytes are essential cells in the human body, which plays a role in preventing ultraviolet rays, which absorb ultraviolet rays of short wavelengths, from penetrating into the dermis, and melanin is produced from the melanocytes of melanocytes. And the appearance of the skin color is determined by the presence of a large number of melanin pigments.

따라서 피부 미백을 유지하거나 또는 개선하기 위하여 멜라닌 생성의 억제와 곤련된 성분들을 화장료 성분에 적용되고 있으며 예를 들면, 멜라닌 생성의 주원인인 자외선 차단을 위해 광산란제 또는 광차단제를 이용하거나 티로시나아제의 활성을 억제와 관련된 성분, 멜라닌을 환원시켜 탈색시키는 성분 등을 화장료 성분에 적용되고 있다.Therefore, in order to maintain or improve skin whitening, the inhibition of melanin production and the applied components are applied to cosmetic ingredients. For example, a light scattering agent or a light blocking agent is used for ultraviolet shielding, which is a main cause of melanin production, A component related to inhibition of activity, a component that decolorizes melanin to reduce it, and the like are applied to cosmetic ingredients.

근래에는 한약재가 보습력과 노화방지기능, 항산화 효과가 우수하다고 보고된 후 화장품 분야에도 한약재의 사용이 두드러져 한약재 추출물을 이용한 화장료 조성물에 대해서도 많은 연구가 되고 있으며, 선행기술로 예를 들면, 국내 등록특허공보 등록번호 제10-1135264호에 자초, 구맥 및 촉규화로 이루어진 한약재 혼합 추출물을 유효성분으로 함유하는 항산화, 항노화, 미백, 주름 개선 또는 보습 효과가 우수한 화장료 조성물을 개시하고 있으며, 국내 등록특허공보 등록번호 제10-1251040호에 마치현, 귤피 및 꽈리열매가 포함된 한약재료가 100중량부로 이루어진 혼합 한약재료 추출물 및 500중량부로 이루어진 황칠나무 추출물로 이루어지되, 상기 혼합 한약재료 추출물 및 상기 황칠나무 추출물을 1 내지 70중량% 포함하고, 잔량으로서 화장품 베이스를 포함하되, 상기 잔량으로서, 달팽이 점액 여과물 1 내지 5중량%를 더 포함하는 것을 특징으로 하는 황칠나무 추출물을 이용한 미백 화장품 조성물을 개시하고 있다.Recently, herbal medicines have been reported to have excellent moisturizing power, anti-aging function and antioxidant effect, and the use of herbal medicines has become prominent in the field of cosmetics. Thus, many studies have been made on cosmetic compositions using herbal medicinal extracts. For example, Discloses a cosmetic composition which is excellent in antioxidation, anti-aging, whitening, wrinkle-improving or moisturizing effect, which contains a mixed extract of herbal medicines composed of herbal medicine, No. 10-1251040 discloses a herbal medicine extract consisting of 100 parts by weight of a herbal medicine material containing marjoram, citrus peel, and acacia fruit, and 500 parts by weight of a herbal extract. 1 to 70% by weight, and the cosmetic base as the remaining amount But also, as the remaining amount, discloses a snail mucus filtrate 1 to hwangchil whitening cosmetic composition using a wood extract to 5% by weight, characterized in that it further comprises.

또한 마태반(Horse placenta)으로부터 추출된 추출물이 색소 침착을 예방하는 작용뿐만 아니라 미백작용도 나타내므로(Mallick Set el., Pigment Cell Res. Feb 18(1), 25-33, 2005) 화장료 및 식품 등의 재료에 사용하고 있으며, 선행기술로 예를 들면, 국내 공개특허공보 공개번호 10-2010-0104144호에 마유 및 마태반 추출물이 내포된 나노리포좀을 유효성분으로 포함하는 피부 미백용 조성물을 개시하고 있으나, 말태반 추출물에서는 특유의 냄새 및 불안정성으로 인해 쉽게 변폐되고, 고농도에서 사용시 피부에 자극이 나타나는 단점이 있다.In addition, since the extracts from the horse placenta exhibit not only the action of preventing pigmentation but also the whitening action (Mallick Set el., Pigment Cell Res. Feb 18 (1), 25-33, 2005) And a composition for skin whitening comprising, as an active ingredient, a nanoliposome containing an extract of Maehu and Matthew halves in Korean Patent Laid-Open Publication No. 10-2010-0104144 as a prior art. However, the horse placenta extract has disadvantages that it is easily discolored due to its unique odor and instability, and irritation occurs to the skin when used at a high concentration.

본 발명은 마태반 발효물에 의해 마태반 특유의 냄새의 제거 및 독성감소와 함께 생약성분을 조합하여 피부에 안전하고, 제형의 안정성이 우수한 피부미백 화장료를 제조함으로써 본 발명을 완성하였다.The present invention has completed the present invention by producing a skin whitening cosmetic which is safe to the skin and has excellent stability of the formulation by combining the herbal ingredients together with the elimination of the odor of the mate- rial semi-fermented product and the reduction of the toxicity.

본 발명은 마태반(Horse placenta) 발효물 및 생약성분을 함유하는 피부 미백 화장료 조성물의 제공을 목적으로 하며, 보다 구체적으로는 마태반 특유의 냄새 및 독성이 감소된 마태반(Horse placenta) 발효물과 생약성분을 이용하여 피부에 매우 안전하고, 미백효과가 우수한 피부미백 화장료 조성물의 제공을 목적으로 하는 것이다.The present invention aims at providing a skin whitening cosmetic composition containing a horse placenta fermented product and a herbal ingredient, and more particularly, to a horse placenta fermented product having a reduced odor and toxicity And to provide a skin whitening cosmetic composition which is very safe on the skin and has excellent whitening effect by using herbal ingredients.

본 발명의 목적을 달성하기 위한 해결수단으로서, 마태반 발효물 및 생약성분을 이용한 피부 미백 화장료 조성물은 마태반 발효물 60 ~ 80중량%, 황칠나무추출물, 유자추출물, 모과추출물, 향나무추출물 및 괴불나무추출물을 각각 4~ 8중량%로 함유하는 활성성분이 화장료 조성물 총중량에 대하여 0.01 ~ 15중량%로 조성되는 것으로 이루어진다.As a solution to achieve the object of the present invention, the skin whitening cosmetic composition using the mathematical semi-fermented product and the herbal composition comprises 60 to 80% by weight of the maturity semi-fermented product, the extract of Huacaraceae, citron extract, And 4 to 8% by weight of wood extracts are each constituted by 0.01 to 15% by weight based on the total weight of the cosmetic composition.

상기 마태반(Horse placenta)은 필수 아미노산, RNA, DNA 등의 핵산성분, 항산화효소인 SOD(Super Oxide Dismutase), 히아루론산(Hyaluronic acid), 항산화제, 면역보조인자(cytocine), 태반펩타이드, 인슐린 유사 성장촉진인자(insulin-like growth factor), 표피성장 촉진인자(EGFS, Epidermal Growth Factors) 및 독특한 노쇠세포활성인자(SCAFS, Senescent Cell Adivating Factors) 등의 성장인자와 싸이토카인류가 포함되어 있어 피로회복, 면역증강 등에 유용한 것으로 알려져 있다.The horse placenta is composed of nucleic acid components such as essential amino acids, RNA and DNA, antioxidant enzymes such as SOD (Super Oxide Dismutase), Hyaluronic acid, antioxidant, immunocompetent factor (cytocine), placental peptide, Growth factors such as insulin-like growth factor, epidermal growth factor (EGFS) and unique senescent cell activating factor (SCAFS), and cytokines such as fatigue recovery, Immune enhancement, etc.

본 발명에 따른 마태반(Horse placenta) 발효물은 태반을 젖산균 속 미생물로부터 선택되는 하나 이상의 미생물을 접종하여 발효온도 38℃에서 10일간 발효시키는 것으로 이루어지며, 이후 미생물에 의한 발효 산물이 안정화되기 위한 숙성 단계를 3개월 정도 수행하며, 이렇게 숙성 과정이 끝난 것을 여과하여 마태반 발효물을 얻는다.The horse placenta fermented product according to the present invention is prepared by inoculating the placenta with at least one microorganism selected from microorganisms of lactic acid bacteria and fermenting the fermented product at a fermentation temperature of 38 ° C for 10 days, The fermentation process is carried out for about 3 months. After the fermentation process is finished, the fermented material is obtained by filtering.

상기 마태반 발효물의 경우 발효과정 중에 조건을 잘못 설정하였을 경우 심한 악취를 동반하면서 부패되는 현상이 나타나며, 바람직한 정상적인 발효의 경우 악취를 동반하지 않으면서 발효액의 pH는 3 내지 4 정도에서 안정적으로 유지되는 특성을 나타낸다. In the case of the above-mentioned mathematical half-fermented product, if the condition is set incorrectly during the fermentation process, there is a phenomenon of spoilage accompanied with a bad odor. In case of normal normal fermentation, the pH of the fermentation broth is stably maintained at about 3 to 4 Lt; / RTI >

상기 본 발명에 따른 젖산균으로는 락토바실러스 속 젖산균(Lactobacillus sp.)으로서, 구체적으로 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 델브루에키(Lactobacillus delbrueckii), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 브레비스(Lactobacillus brevis), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 페디오코커스 펜토사세우스(Pediococcus pentosaceus), 페디오코커스 세레비세(Pediococcus cerevisiae), 락토코커스 락티스 (Lactococcus lactis), 레코노스톡 시트레움(Leuconostoc citreum), 레코노스톡 메센테로이드(Leuconostoc mesenteroides), 비피도박테리움 비피둠(Bifidobacterium bifidum), 락토바실러스 헬벳티커스(Lactobacillus helveticus) 로부터 하나 이상이 선택되는 것으로 이루어진다.Examples of the lactic acid bacteria according to the present invention include Lactobacillus sp. Lactobacillus sp., Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus brevis, Lactobacillus acidophilus, Pediococcus pentosaceus, Pediococcus cerevisiae, Lactobacillus spp., Lactobacillus spp., Lactobacillus spp., Lactobacillus spp. One from Lactococcus lactis, Leuconostoc citreum, Leuconostoc mesenteroides, Bifidobacterium bifidum, and Lactobacillus helveticus. One is from Lactococcus lactis, Leuconostoc citreum, Leuconostoc mesenteroides, Bifidobacterium bifidum and Lactobacillus helveticus. Or more.

본 발명에 따른 마태반 발효물은 사용하는 미생물 균의 종류에 따라 항산화 활성이 서로 상이하게 나타나지만, 본 발명에서는 락토바실러스 속 젖산균들 중 마태반 발효물의 항산화 활성을 향상시키는 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 델브루에키(Lactobacillus delbrueckii), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 헬벳티커스(Lactobacillus helveticus) 등이 바람직하지만, 이들 중에 락토바실러스 헬벳티커스(Lactobacillus helveticus)를 사용하는 것이 보다 바람직하다.The antimicrobial activity of the mate- rial fermented product according to the present invention varies according to the kind of the microorganism to be used. However, in the present invention, Lactobacillus (Lactobacillus sp. plantarum, Lactobacillus delbrueckii, Lactobacillus acidophilus, and Lactobacillus helveticus are preferred. Among them, Lactobacillus helveticus is preferred, and Lactobacillus spp. It is more preferable to use it.

또 상기 본 발명의 황칠나무, 유자, 모과, 향나무 및 괴불나무는 한약재 등 약용식물로 널리 알려진 식물이며, 황칠나무 추출물은 잘 건조한 황칠나무를 80℃의 열수로 3 ~ 5시간 추출한 후, 냉각한 다음, 여과한 것을 사용하며, 유자, 모과, 향나무, 괴불나무도 동일한 방법으로 추출하여 얻는다.In addition, the present invention is a plant widely known as a medicinal plant such as Huangchu, Yuzu, Juza, Jiangsu, Jiangsu, and Nanbu trees, and the Huangchu tree extract is obtained by extracting well dried Huangchu tree with hot water at 80 ° C for 3 to 5 hours, Next, the filtrate is used, and citron, quince, juniper, and necropolis are extracted by the same method.

상기 황칠나무, 유자, 모과, 향나무 및 괴불나무 각각의 추출물은 고형분 함량이 추출물 중량비 기준으로 0.1 ~ 2.0 중량%의 비율을 가지는 것이 바람직하며, 고형분 함량이 2.0 중량%를 초과하여 높으면 추출물의 침전 현상 등이 나타나 산업화에 어려움이 있다.It is preferable that the extracts of each of the above-mentioned woody spruce, citron, citrus fruit, jasmine, and nematode have a solid content ratio of 0.1 to 2.0 wt% based on the weight ratio of the extract. If the solid content exceeds 2.0 wt% There are difficulties in industrialization.

본 발명의 마태반 발효물 및 생약성분 추출물을 이용한 피부미백 화장료 조성물은 마태반의 발효물을 시용함으로써 특유의 냄새가 제거되고, 독성이 없으므로 피부에 비자극성이고, 안전하여 피부에 대한 부작용이 없으며 또한 항산화작용과 면역 강화기능이 강화되는 효과에 의해 우수한 미백효과를 나타낸다.The skin whitening cosmetic composition using the matthews half fermented product and herbal medicine component extract of the present invention is a non-irritating, safe, non-toxic and non-toxic skin by removing the characteristic odor by using the fermented product of the martial arts. It shows excellent whitening effect by the effect of strengthening antioxidant and immunity strengthening function.

도 1은 마태반 발효물과 생약성분 추출물의 혼합물의 멜라닌 생성 억제에 대한 영상물.
도 2는 마태반 발효물과 생약성분 추출물의 혼합물을 함유하는 제형예 3의 사용 전/후 기미의 감소를 관찰한 영상물.
Fig. 1 is a picture of the inhibition of melanin formation by a mixture of a fermented product of Matthias mellifera and a herbal medicine ingredient extract.
FIG. 2 is a graph showing a decrease in the pre- and post-use staining of Formulation Example 3 containing a mixture of the maturity-half fermented product and the herbal medicine component extract.

이하, 본 발명의 실시를 위하여 실시예 및 시험예에 의해 구체적으로 설명하기로 하겠으나, 본 발명은 하기에서 설명하는 실시예에 의하여 제한되는 것은 아니다. Hereinafter, the present invention will be described in detail with reference to Examples and Test Examples. However, the present invention is not limited by the following examples.

<실시예 1>&Lt; Example 1 >

1). 마태반 발효물 제조One). Manufacture of fermented mate

마태반은 채취하는 즉시 동결 상태로 보관하다가 발효 공정시 해동하여 사용하였다. 동결하여 분쇄한 마태반 분쇄물 2Kg에 설탕 200g, 올리고당 300g을 첨가하여 혼합 한 후 락토바실러스 헬벳티커스(Lactobacillus helveticus)를 3%(w/v)로 접종하여 발효 온도 38℃에서 10일간 발효하였다.The matthews were stored frozen immediately after harvesting and thawed during the fermentation process. 200 g of sugar and 300 g of oligosaccharide were added to 2 kg of freeze-crushed matte semi-pulverized product, and the mixture was inoculated with 3% (w / v) of Lactobacillus helveticus and fermented at a fermentation temperature of 38 ° C for 10 days .

이후 미생물에 의한 발효산물을 안정화하기 위하여 3개월 정도 실온에서 숙성하였으며, 이렇게 숙성 과정이 끝난 것을 여과하여 마태반 발효물을 수득하였으며, 수득한 마태반 발효물의 고형분 함량은 1.2중량% 였으며, pH는 3.5로 확인되었다.Thereafter, the fermentation product was aged at room temperature for about 3 months. After completion of the fermentation process, the fermented product was filtered to obtain a fermented product. The obtained fermented product had a solid content of 1.2 wt% 3.5.

2). 생약성분 추출물 제조2). Production of herbal medicine ingredient extract

잘 건조한 황칠나무 1Kg을 80℃의 열수로 4시간 동안 추출한 후 실온까지 냉각하고, 여과하여 추출액을 수득하였다. 수득된 추출물의 고형분 함량은 추출물 중량비 기준으로 1.5중량%를 가지며, pH는 6으로 확인되었다1 Kg of well-dried Hwangryu-jinhwa was extracted with hot water of 80 캜 for 4 hours, cooled to room temperature, and filtered to obtain an extract. The solids content of the extract obtained was 1.5% by weight based on the weight of the extract and the pH was found to be 6

또 유자, 모과, 향나무, 괴불나무도 동일한 방법으로 추출하여 각각의 추출액을 수득하였다.In addition, citron, quince, juniper, and nunchaku were extracted by the same method to obtain respective extracts.

3). 마태반 발효물과 생약성분 추출물의 혼합물(활성성분) 제조3). Manufacture of a mixture (active ingredient) of a fermented mate-rial and herbal extracts

상기에 제조한 마태반 발효물과 생약성분 추출물을 배합하여 본 발명에 따른 마태반 발효물과 생약성분 추출물의 혼합물(활성성분)을 제조하였으며, 배합비율은 마태반 발효물 75중량%, 황칠나무추출물, 유자추출물 , 모과추출물, 향나무추출물, 괴불나무추출물이 각각 5중량%로 되도록 배합하였다.A mixture (active ingredient) of the matthews fermented product according to the present invention and the herbal medicine component extract (active ingredient) was prepared by mixing the above-prepared matthews semi-fermented product with the herbal medicine component extract. The compounding ratio was 75 wt% Extracts, citron extracts, mosses extracts, jungle extracts, and nematode extracts were each adjusted to 5% by weight.

상기 <실시예 1>에서 제조한 본 발명에 따른 활성성분인 말태반 발효물과 생약성분 추출물의 혼합물(활성성분)을 이용하여 아래 <시험예>와 같이 피부미맥 효과에 대하여 시험하였다.The skin macerating effect was tested using the mixture (active ingredient) of the horse-placenta fermented product as an active ingredient according to the present invention prepared in Example 1 and the herbal medicine ingredient extract as follows.

<시험예1> In vitro tyrosinase 활성저해시험 &Lt; Test Example 1 > In vitro tyrosinase activity inhibition test

타이로시나제는 인체내의 멜라닌 생합성 경로에서 가장 중요한 초기속도결정단계에 관여하는 효소로서 많은 미백 성분이 이 효소를 억제하는 작용기전을 가지고 있으므로 이 시험은 시험관내에서 타이로시나제효소의 활성을 저해하는 정도를 평가하는 방법이며, 시료는 에탄올이나 적당한 용매에 녹여 타이로시나제활성을 억제하기 위한 적당한 농도범위로 희석한 것을 시료액으로 한다(최소 5개의 농도범위). Tyrosinase is an enzyme involved in determining the most important initial rate in the melanin biosynthetic pathway in the human body. Since many whitening ingredients have an action mechanism that inhibits this enzyme, this test shows the activity of tyrosinase enzyme in vitro The sample is diluted to a suitable concentration range to inhibit tyrosinase activity by dissolving in ethanol or an appropriate solvent. The sample solution is a sample solution (minimum of 5 concentration ranges).

시험관에 0.1 M 인산염완충액(pH 6.5) 220 ㎕와 시료액 20 ㎕ 그리고 머쉬룸 타이로시나제(1500 ~ 2000U/㎖)(혹은 휴먼 타이로시나제)액 20 ㎕를 순서대로 넣는다. 이 용액에 1.5 mM 타이로신 액 40 ㎕를 넣고 37℃에서 10 ~ 15분 동안 반응시킨다.Add 220 μl of 0.1 M phosphate buffer (pH 6.5), 20 μl of sample solution and 20 μl of mushroom tyrosinase (1500-2000 U / ml) (or human tyrosinase) solution in the test tube in this order. Add 40 μl of 1.5 mM tyrosine solution to this solution and incubate at 37 ° C for 10 to 15 minutes.

그리고 이것을 ELISA reader를 이용하여 490nm에서 흡광도를 측정한다. 공시료액으로 시료액 대신 0.1 M인산염완충액(pH 6.5)을 넣는다. 활성저해율이 50 %일 때의 시료의 농도(IC50)를 적절한 프로그램을 이용하여 산출한다. 결과를 아래 [표1]에 나타내었다. 실험조건에 따라 다른 스케일의 실험도 가능하다. 또한, 양성대조군은 알부틴 또는 에칠아스코빌에텔 등을 사용할 수 있다. The absorbance is measured at 490 nm using an ELISA reader. Add 0.1 M phosphate buffer (pH 6.5) instead of the sample solution to the blank. The concentration (IC50) of the sample when the active inhibition rate is 50% is calculated using an appropriate program. The results are shown in Table 1 below. It is possible to experiment with different scales depending on the experimental conditions. As the positive control group, arbutin or ethyl ascorbyl ether can be used.

타이로시나제 활성저해율(%)=100-(b-b'/a-a')×100(%) = 100- (b-b '/ a-a') 100

상기식에서, a : 공시료액의 반응 후의 흡광도, b : 시료액의 반응 후의 흡광도. a', b' : 타이로시나제대신 완충액으로 대체하여 측정한 흡광도A: absorbance of the blank after the reaction, and b: absorbance of the sample after the reaction. a ', b': absorbance measured by replacing with buffer instead of tyrosine

IC50 티로시나제 억제 농도 (ppm)IC50 tyrosinase inhibitory concentration (ppm) 비고Remarks Vitamin CVitamin C 5555 마태반 발효물과 생약성분 추출액의 혼합물Mixture of Fermented Maceous and Fermented Extracts 310310

상기 [표 1]에 나타난 결과를 살펴보면 마태반 발효물과 생약성분 추출액의 혼합물의 IC50값이 비타민 C에 비하여 높지만 비타민 C는 순수한 단일 화합물인 반면, 본 발명은 마태반 발효물과 생약성분 추출물의 혼합물이라는 것을 감안하면 티로시나제 억제 활성은 매우 우수하다고 할 수 있다.As shown in Table 1, the IC50 value of the mixture of the fermentation product of mata-fermented product and the herbal medicine ingredient is higher than that of vitamin C, whereas the vitamin C is a pure single compound. On the other hand, It can be said that the tyrosinase inhibitory activity is very excellent.

<시험예 2> 멜라닌 생성 억제 시험 Test Example 2 Melanin production inhibition test

본 <시험예 2>에서는 마우스에서 유래한 세포균주로서 멜라닌 흑색색소를 분비하는 B16-F1 멜라노마세포를 인공배양하면서 본 발명의 마태반 발효물과 생약성분 추출물의 혼합물을 처리하여 멜라닌 흑색색소가 감소하는 정도를 비교 평가하였다.In this <Test Example 2>, B16-F1 melanoma cells secreting melanin black pigment were cultured as a cell strain derived from a mouse, and a mixture of the matal-fermented product of the present invention and the herbal medicine ingredient extract was treated to obtain melanin black pigment Compared with the control group.

본 발명에 사용한 B16-F1 멜라노마세포의 균주 번호는 ATCC6323이었다. B16 멜라노마 세포의 멜라닌 생합성 저해도 판별을 위하여, B16 멜라노마 세포를 5× 104 cells/㎖의 농도로 10% 소태아혈청을 포함하는 현탁액으로 현탁시키고, 현탁세포 5㎖를 조직배양 플라스크에 넣은 후 검정시료를 0.134% 첨가하여, 5% 이산화탄소와 95%의 공기 조건을 가지는 CO2 인큐베이터에서 37℃로 4일간 배양한 후, 배양액의 색으로 멜라닌생성 정도를 1차 판별하고, 세포를 인산완충액으로 씻은 후 트립신 처리하여 세포를 플라스크로부터 분리하였다.The strain number of the B16-F1 melanoma cell used in the present invention was ATCC6323. For the inhibition of melanin biosynthesis of B16 melanoma cells, B16 melanoma cells were suspended in a suspension containing 10% fetal bovine serum at a concentration of 5 x 10 4 cells / ml, and 5 ml of the suspension cells were suspended in a tissue culture flask , 0.134% of a black sample was added thereto, and the mixture was incubated at 37 ° C for 4 days in a CO 2 incubator having 5% carbon dioxide and 95% air conditions. The degree of melanin production was firstly discriminated by the color of the culture medium, Washed with buffer and trypsinized to separate the cells from the flask.

그리고 세포를 튜브에 모은 후 인산완충액으로 씻고, 원심분리하여 튜브 아래쪽에 침전된 멜라닌 생성양을 기존의 미백제로 알려지고 있는 kojic acid와 비교하였다. 평가 방법은 세포배양 중에 아무것도 처리하지 않은 것과 각 시료를 처리했을 때의 검은 멜라닌색소 분비정도에 따라 색상이 변화되는 정도를 육안 관찰하는 방법을 택하였다. Cells were collected in tubes, washed with phosphate buffer, centrifuged, and the amount of melanin precipitated at the bottom of the tube was compared with the known kojic acid. The evaluation method was to visually observe the degree of color change depending on the degree of secretion of black melanin pigment when no treatment was performed during cell culture and when each sample was treated.

결과를 [도 1]로 첨부하였으며, [도 1]에 나타난 결과로부터 본 발명의 마태반 발효물과 생약성분 추출액의 혼합물이 효과적으로 멜라닌 색소 생성을 억제한다는 결론을 얻었다.The results are shown in FIG. 1, and it was concluded from the results shown in FIG. 1 that the mixture of the mash fermented product of the present invention and the herbal composition extract effectively inhibited melanin pigment formation.

<실시예 2> 화장품 제형 제조&Lt; Example 2 > Preparation of Cosmetic Formulation

아래 <제형예>들은 본 발명의 이해를 돕기 위한 예시한 것이며, 본 발명이 아래 제형예에 국한되는 것은 아니다.The following <Formulation Examples> are given to aid understanding of the present invention, and the present invention is not limited to the following Formulation Examples.

a). 제형예 1: 스킨 토너a). Formulation Example 1: Skin Toner INCI NameINCI Name 분량 (g)Quantity (g) 비고Remarks PropandiolPropanediol 7.007.00 Dipotassium glycyrrhizateDipotassium glycyrrhizate 0.100.10 AllantoinAllantoin 0.100.10 PEG-60 hydrogenated castor oilPEG-60 hydrogenated castor oil 0.200.20 DipropyleneglycolDipropyleneglycol 5.005.00 GlycerinGlycerin 4.004.00 Sodium carbomerSodium carbomer 0.150.15 PhenoxyethanolPhenoxyethanol 0.300.30 마태반 발효물과 생약성분 추출액의 혼합물Mixture of Fermented Maceous and Fermented Extracts 0.100.10 HexanediolHexanediol 2.002.00 WaterWater to 100.00to 100.00

b). 제형예 2: 세럼b). Formulation Example 2: Serum INCI NameINCI Name 분량 (g)Quantity (g) 비고Remarks ButandiolButandiol 10.0010.00 Dipotassium glycyrrhizateDipotassium glycyrrhizate 0.100.10 AllantoinAllantoin 0.100.10 PEG-40 Hydrogenated Castor OilPEG-40 Hydrogenated Castor Oil 0.100.10 AdenosineAdenosine 0.040.04 Acrylates/C10-30 alkyl acrylate crosspolymerAcrylates / C10-30 alkyl acrylate crosspolymer 0.150.15 Xanthan gumXanthan gum 0.050.05 PhenoxyethanolPhenoxyethanol 0.300.30 MethylparabenMethylparaben 0.200.20 Water, Butylene glycol, Glycerine, Copper Tripeptide-1, Phenoxyethanol, Methylparaben, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben, PEG-40 hydrogenated castor oil, PPG-26-Buteth-26PEG-40 hydrogenated castor oil, PPG-26-Buteth-26, butylene glycol, glycerine, Copper Tripeptide-1, Phenoxyethanol, Methylparaben, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben,

0.01


0.01
Water, Lysine, Histidine, Arginine, Aspartic acid, Threonine, Serine, Glutamic acid, Proline, Glycine, Alanine, Valine, Methionine, Isoleucine, Leucine, Tyrosine, Phenylalanine, CysteineLysine, Histidine, Arginine, Aspartic acid, Threonine, Serine, Glutamic acid, Proline, Glycine, Alanine, Valine, Methionine, Isoleucine, Leucine, Tyrosine, Phenylalanine, Cysteine

0.01


0.01
Acetyl hexapeptide-8Acetyl hexapeptide-8 0.100.10 마태반 발효물과 생약성분 추출액의 혼합물Mixture of Fermented Maceous and Fermented Extracts 1.001.00 WaterWater to 100.00to 100.00

c). 제형예 3: 영양크림c). Formulation Example 3: Nourishing cream INCI NameINCI Name 분량 (%)amount (%) 비고Remarks GlycerinGlycerin 5.005.00 AllantoinAllantoin 0.100.10 Dipotassium glycyrrhizateDipotassium glycyrrhizate 0.100.10 PropanediolPropanediol 5.005.00 Sparassis crispa extractSparassis crispa extract 1.501.50 Lactobacillus/Soymilk ferment extractLactobacillus / Soymilk ferment extract 1.001.00 Hydrogenated lecithinHydrogenated lecithin 1.001.00 마태반 발효물과 생약성분 추출액의 혼합물Mixture of Fermented Maceous and Fermented Extracts 5.005.00 Xanthan gumXanthan gum 0.100.10 BentoniteBentonite 0.400.40 Cetearyl alcoholCetearyl alcohol 1.501.50 Glyceryl stearate, PEG-100 stearateGlyceryl stearate, PEG-100 stearate 1.001.00 Simmondsia chinensis (Jojoba) seed oilSimmondsia chinensis (Jojoba) seed oil 1.001.00 Macadamia ternifolia seed oilMacadamia ternifolia seed oil 1.001.00 Butyrospermum parkii (Shea butter)Butyrospermum parkii (Shea butter) 1.001.00 Cetearyl olivate, Sorbitan olivateCetearyl olivate, Sorbitan olivate 3.003.00 Tocopheryl acetateTocopheryl acetate 0.400.40 DimethiconeDimethicone 1.001.00 Caprylhydroxamic acid, Caprylyl glycol, GlycerinCaprylhydroxamic acid, Caprylyl glycol, Glycerin 0.500.50 PhenoxyethanolPhenoxyethanol 0.300.30 WaterWater to 100.00to 100.00

d). 제형4: 아이크림d). Formulation 4: Eye Cream INCI NameINCI Name 분량 (%)amount (%) 비고Remarks GlycerinGlycerin 5.005.00 Pentylene glycolPentylene glycol 3.503.50 Glucose, Sorbitol, Citric acidGlucose, Sorbitol, Citric acid 0.100.10 Butylene glycolButylene glycol 3.003.00 Water, Sodium hyaluronateWater, Sodium hyaluronate 7.007.00 Water, btylene glycol, carbomer, sodium stearate, hydrolyzed wheat protein, zinc gluconate, atelocollagen, Sodium Chondroitin SulfateWater, btylene glycol, carbomer, sodium stearate, hydrolyzed wheat protein, zinc gluconate, atelocollagen, Sodium Chondroitin Sulfate
0.50

0.50
Disodium EDTADisodium EDTA 0.030.03 PetrolatumPetrolatum 4.004.00 Mineral oil, Lanolin alcoholMineral oil, Lanolin alcohol 2.002.00 CeresinCeresin 3.003.00 Butyrospermum parkii (Shea butter)Butyrospermum parkii (Shea butter) 4.004.00 Lauryl PEG-9 polydimethylsiloxyethyl dimethiconeLauryl PEG-9 polydimethylsiloxyethyl dimethicone 2.002.00 Phenyl trimethiconePhenyl trimethicone 4.004.00 Limnanthes alba (Meadowfoam) seed oilLimnanthes alba (Meadowfoam) seed oil 2.002.00 Vitis vinifera (Grape) seed oilVitis vinifera (Grape) seed oil 1.001.00 Tocopheryl acetateTocopheryl acetate 0.500.50 SilicaSilica 0.500.50 Arachidyl alcohol, Behenyl alcohol, Arachidyl glucosideArachidyl alcohol, Behenyl alcohol, Arachidyl glucoside 2.002.00 PEG-8 DilauratePEG-8 Dilaurate 1.001.00 마태반 발효물과 생약성분 추출액의 혼합물Mixture of Fermented Maceous and Fermented Extracts 15.0015.00 PhenoxyethanolPhenoxyethanol 0.300.30 Caprylhydroxamic acid, Caprylyl glycol, GlycerinCaprylhydroxamic acid, Caprylyl glycol, Glycerin 0.500.50 FragranceFragrance 0.100.10 WaterWater to 100.00to 100.00

본 발명의 화장료 조성물은 일반 피부도포용 화장료에 배합되는 보통의 성분을 필요한 만큼 적용 배합하는 것이 가능하다. 본 발명에 따른 화장료 조성물의 유상 성분 함량은 유화 능력의 보강 및 경제성 등을 고려하여 선택되며, 유상 성분으로서 주로 사용될 수 있는 오일로는 식물성 오일, 광물성 오일, 실리콘유 및 합성유 중에서 선택된 하나 이상을 사용할 수 있다. 이 외에 유화 능력을 보강하기 위하여 계면활성제, 고급알콜 등을 0.1 내지 5 중량% 첨가할 수 있다. 이러한 계면 활성제로는 비이온 계면활성제, 인지질 등과 같은 통상적인 계면활성제를 사용할 수 있으며, 고급 알콜로는 탄소수가 12 내지 20인 알콜을 단독으로 또는 1종 이상 혼합하여 사용할 수 있다. The cosmetic composition of the present invention can be blended with an ordinary ingredient to be incorporated in a cosmetic composition for general skin. The oil component content of the cosmetic composition according to the present invention is selected in consideration of enhancement of emulsifying ability and economical efficiency, and at least one oil selected from vegetable oil, mineral oil, silicone oil and synthetic oil can be used . In addition, 0.1 to 5% by weight of a surfactant, a higher alcohol and the like may be added to reinforce the emulsifying ability. As such surfactants, conventional surfactants such as nonionic surfactants, phospholipids and the like can be used. As the higher alcohols, alcohols having 12 to 20 carbon atoms can be used singly or in combination.

또한 화장료 조성물에 있어서, 수상 성분은 수상의 점도 또는 경도를 조절하기 위하여 카보머, 잔탄검, 벤토나이트 등과 같은 1종 이상의 점증제를 0.001 내지 5 중량% 더 첨가할 수 있다. 또한, 본 발명의 조성물에는 필요에 따라 고급 지방산, 비타민 등의 약효 성분과 자외선 차단제, 산화 방지제, 방부제, 향료, 착색제, pH 조절제 등 통상적인 화장품에서 사용되는 성분을 더 첨가할 수 있다. 본 발명의 화장료 조성물은 피부를 통해 흡수되는 제품으로, 유연화장수(스킨), 수렴화장수, 영양화장수(로션), 세안제, 영양크림, 맛사지크림, 에센스, 겔, 팩, 파우더, 피부외용연고, 첩포제, 현탁액, 에멀젼, 스프레이, 또는 미용액 등의 통상의 화장료 형태로 제조될 수 있으며, 이들 각 제형에 적합하고 당업계에 주지된 각종의 통상적인 담체와 첨가제를 포함할 수 있다.In addition, in the cosmetic composition, 0.001 to 5% by weight of one or more kinds of thickening agents such as carbomer, xanthan gum, bentonite and the like may be further added in order to control the viscosity or hardness of the water phase. In addition, the composition of the present invention may further contain a pharmaceutical ingredient such as higher fatty acids and vitamins, and components used in conventional cosmetics such as an ultraviolet screening agent, an antioxidant, a preservative, a flavoring agent, a coloring agent, and a pH adjusting agent. The cosmetic composition of the present invention is a product which is absorbed through the skin, and is a softening product (skin), a convergent lotion, a nutritional lotion (lotion), a cleanser, a nutritional cream, a massage cream, an essence, a gel, a pack, a powder, Emulsion, spray, or serum, and may contain various conventional carriers and additives suitable for each of these formulations and known in the art.

이상, 본 발명의 이해를 돕기 위하여 바람직한 제형예를 제시하였지만, 상기의 제형예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 이에 의해 본 발명의 내용이 한정되는 것은 아니다.While the present invention has been described with reference to certain preferred embodiments, it is to be understood that the invention is not limited to the disclosed embodiments.

제형예의 마태반 발효물과 생약성분 추출물의 혼합물 첨가비율은 제형의 안정성과 기호성을 고려하여 화장료조성물 총 중량에 대하여 0.01 ~ 15중량%까지 첨가가 가능하며, 0.01중량% 이하에서는 효능/효과가 부족하고, 15중량% 이상에서는 제형의 안정성이 떨어지며, 베이스 취에 의한 변취 가능성 등이 높아 산업적으로 적용하기 곤란하므로 마태반 발효물과 생약성분 추출물의 혼합물이 화장료조성물 총 중량에 대하여 0.1 ~ 15중량% 범위로 첨가되는 것이 바람직하다.Fermented product of the present invention can be added in an amount of 0.01 to 15% by weight based on the total weight of the cosmetic composition in consideration of the stability and palatability of the formulation, and when the amount is less than 0.01% by weight, the efficacy / Fermented product and the herbal medicine component extract are contained in an amount of 0.1 to 15 wt% based on the total weight of the cosmetic composition, and since the stability of the formulation is low at 15 wt% or more, By weight.

<시험예 3> 화장품 제형의 안정도 시험&Lt; Test Example 3 > Stability test of cosmetic formulation

상기 <실시예 2>에서 제조한 제형예들을 대상으로 장기보존시험 (온도:25± 2 ℃/상대습도:60± 5 %), 가속시험 (온도 : 40 ± 2℃/상대습도 : 75 ± 5%), 가혹시험 (1 cycle : 40 ℃, 8 hrs → 20 ℃, 8hrs → 0 ℃, 8 hrs)을 실시하였으며, 모든 제형예들이 장기보존시험은 6개월, 가속시험은 3개월, 가혹시험은 1개월 이상 상의 분리, 친전, 변색 등 물리화학적 변화가 관찰되지 않아 매우 안정적인 제형을 가지고 있음을 확인하였다.The formulation examples prepared in Example 2 were subjected to a long-term preservation test (temperature: 25 ± 2 ° C. / relative humidity: 60 ± 5%) and an accelerated test (temperature: 40 ± 2 ° C. / relative humidity: 75 ± 5 All tests were performed for 6 months for the long-term storage test, 3 months for the accelerated test, and 10 days for the severe test. The physicochemical changes such as separation, electrophoresis and discoloration of more than 1 month were not observed and it was confirmed that the formulation had a very stable formulation.

<시험예 4> 제형예의 피부 미백 효과 검증Test Example 4: Verification of Skin Whitening Effect in Formulation Example

상기 <실시예 2>에서 제조한 제형예 3의 영양크림을 대상으로 기미가 있는 여성에게 6주간 사용하게 한 후 피부의 기미가 변화하는 것을 관찰하였다. 그 결과를 [도 2]로 첨부하였으며,[도 2]에서 보는 것과 같이 피부의 기미가 옅어지고 피부색상이 전반적으로 밝아지는 결과를 확인할 수 있다.The nutritional cream of Formulation Example 3 prepared in Example 2 was used for six weeks in a stigmatized woman, and skin staining changes were observed. The results are shown in [Fig. 2], and as shown in Fig. 2, skin stains are reduced and skin color is generally brightened.

Claims (5)

마태반 발효물과, 황칠나무추출물, 유자추출물, 모과추출물, 향나무추출물 및 괴불나무추출물로 조성되는 활성성분이 화장료 조성물 총중량에 대하여 0.01 ~ 15중량% 함유하는 것을 특징으로 하는 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물.Fermented product of Matthews semi-fermented product, an active ingredient comprising an extract of Huacaraceae, citron extract, mosquito extract, juniper extract and granulosa extract, in an amount of 0.01 to 15% by weight based on the total weight of the cosmetic composition, Composition for skin whitening cosmetic composition. 청구항 1에 있어서, 활성성분이 마태반 발효물 60 ~ 80중량%, 황칠나무추출물, 유자추출물, 모과추출물, 향나무추출물 및 괴불나무추출물을 각각 4 ~ 8중량%로 이루어지는 것을 특징으로 하는 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물.The fermented milk according to claim 1, wherein the active ingredient is composed of 60 to 80% by weight of a fermented macening product, 4 to 8% by weight of an extract of Huaculi, Yuza, Morinda, A skin whitening cosmetic composition using water and herbal ingredients. 청구항 2에 있어서, 활성성분이 마태반발효물 75중량%, 황칠나무추출물 5중량%, 유자추출물 5중량%, 모과추출물 5중량%, 향나무추출물 5중량% 및 괴불나무추출물 5중량%로 이루어진 것을 특징으로 하는 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물.The method according to claim 2, wherein the active ingredient is composed of 75% by weight of a fermented mate- rial fermented product, 5% by weight of Houttuynia cordata extract, 5% by weight of citron extract, 5% by weight of corn extract, 5% Characterized in that it is a skin whitening cosmetic composition using a fermented product of Matthias and herbal ingredients. 청구항 1 내지 청구항3 중 어느 하나의 항에 있어서, 마태반 발효물은 마태반을 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 델브루에키(Lactobacillus delbrueckii), 락토바실러스 아시도필루스(Lactobacillus acidophilus) 및 락토바실러스 헬벳티커스(Lactobacillus helveticus)로부터 선택되는 하나 이상의 균주에 의해 발효시킨 다음, 발효산물을 3개월 숙성시키는 것을 특징으로 하는 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물.The method according to any one of claims 1 to 3, wherein the semi-fermented product of Matthias comprises a matte bacterium selected from the group consisting of Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus acidophilus ) And Lactobacillus helveticus, and fermenting the fermented product for 3 months. The skin whitening cosmetic composition according to claim 1, wherein the fermented product is aged for 3 months. 청구항 4에 있어서, 화장료 조성물은 유연화장수(스킨), 수렴화장수, 영양화장수(로션), 세안제, 영양크림, 맛사지크림, 에센스, 겔, 팩, 파우더, 피부외용연고, 첩포제, 현탁액, 에멀젼, 스프레이 또는 미용액의 제형인 것을 특징으로 하는 마태반 발효물 및 생약성분을 이용한 피부미백 화장료 조성물.The cosmetic composition according to claim 4, wherein the cosmetic composition is at least one selected from the group consisting of softening longevity (skin), convergent lotion, nutritional lotion (lotion), cleanser, nutritional cream, massage cream, essence, gel, pack, powder, ointment, Wherein the composition is a spray, or a formulation of a serum.
KR1020140042396A 2014-04-09 2014-04-09 Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta KR101658799B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140042396A KR101658799B1 (en) 2014-04-09 2014-04-09 Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140042396A KR101658799B1 (en) 2014-04-09 2014-04-09 Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta

Publications (2)

Publication Number Publication Date
KR20150117091A true KR20150117091A (en) 2015-10-19
KR101658799B1 KR101658799B1 (en) 2016-09-23

Family

ID=54399437

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140042396A KR101658799B1 (en) 2014-04-09 2014-04-09 Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta

Country Status (1)

Country Link
KR (1) KR101658799B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2639094C1 (en) * 2017-03-17 2017-12-19 Светлана Алексеевна Сбежнева Method for production of composition for skin regeneration

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006321781A (en) * 2005-04-18 2006-11-30 Snowden Co Ltd High functionality-imparting cosmetic composition
KR20110017742A (en) * 2009-08-14 2011-02-22 문상욱 Fermented placenta compositin and use thereof
KR20120012918A (en) * 2010-08-03 2012-02-13 박숙우 Manufacturing method and cosmetic ingredient using Dendropanax morbifera Lev extraction fluid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006321781A (en) * 2005-04-18 2006-11-30 Snowden Co Ltd High functionality-imparting cosmetic composition
KR20110017742A (en) * 2009-08-14 2011-02-22 문상욱 Fermented placenta compositin and use thereof
KR20120012918A (en) * 2010-08-03 2012-02-13 박숙우 Manufacturing method and cosmetic ingredient using Dendropanax morbifera Lev extraction fluid
KR101251040B1 (en) * 2010-08-03 2013-04-04 박숙우 Manufacturing method and cosmetic ingredient using Dendropanax morbifera Lev extraction fluid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2639094C1 (en) * 2017-03-17 2017-12-19 Светлана Алексеевна Сбежнева Method for production of composition for skin regeneration

Also Published As

Publication number Publication date
KR101658799B1 (en) 2016-09-23

Similar Documents

Publication Publication Date Title
KR20190056177A (en) Cosmetic comoposition for antibacterial comprising Lactobacillus plantarum culture
KR102194315B1 (en) Antioxidant or skin microbiome balance cosmetic composition comprising centella asiatica fermented extract fermented by inoculating lactobacillus rhamnosus strain
CN111465386B (en) Cosmetic composition for improving skin wrinkles comprising lactobacillus plantarum culture
KR101782307B1 (en) Cosmetic composition for Anti-aging comprising Agastache rugosa Kentz extract
KR101911078B1 (en) Composition for improving acneform skin conditions Comprising Complex Extracts of Swallow&#39;s Nest as Active Ingredient
JP2018020990A (en) External preparation for skin
KR20160129453A (en) Cosmetic composition for skin winkle improvement containing Fermented extract of horse placenta and horse oil
JP6321401B2 (en) Cosmetics
KR102350857B1 (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
JP2023171950A (en) Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic
KR102076656B1 (en) A cosmetic composition for improving skin aging comprising an extract of femented barley using lactobacillus sp. complex strain as an active ingredient
KR101855206B1 (en) Cosmetic Composition Comprising the Fermented Extract of Panax ginseng
JP2019038760A (en) Skin external preparation
KR20210155989A (en) Composition Comprising Lactobacillus sakei, Culture Fluid, or Culture Fluid Extract thereof with Anti-Wrinkling and Elasticity, Skin Cell Regeneration, and Skin Barrier Property as Active Ingredient
KR20180071721A (en) Composition for antioxidant or improving skin wrinkle comprising fermented Cudrania tricuspidata extract
KR101658799B1 (en) Cosmetic composition having skin-lightening effect containing Natural component and the Fermented extract of horse placenta
KR101995557B1 (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR101960571B1 (en) Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract
KR102544792B1 (en) Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient
KR101658796B1 (en) Cosmetic composition having anti-wrinkle effect containing Natural component and the Fermented extract of horse placenta
KR102154139B1 (en) Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract
KR102111085B1 (en) Method for fermenting polygonum indigo using nuruk and Cosmetic composition using fermented polygonum indigo extract obtained by the same
KR20220141191A (en) Composition for Skin Whitening, Moisturizing, Strengthening Skin Barrier, Skin Cell Regeneration, and Anti-Wrinkle Property Comprising Fermented Extract of Broussonetia kazinoki as Active Ingredient
KR20220057360A (en) Composition for improving skin beauty comprising fermented hibiscus extract
KR102194314B1 (en) Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
FPAY Annual fee payment

Payment date: 20190902

Year of fee payment: 4